CSPC Pharmaceutical Group Limited Cash Flow Conversion Efficiency

Latest as of June 2020: 0.104x

CSPC Pharmaceutical Group Limited cash flow conversion efficiency. Based on the latest financial reports, CSPC Pharmaceutical Group Limited (CVG) has a cash flow conversion efficiency ratio of 0.104x as of June 2020. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€2.16 Billion ≈ $2.52 Billion USD) by net assets (€20.71 Billion ≈ $24.21 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of CSPC Pharmaceutical Group Limited (2013–2025)

Cash flow conversion efficiency of CSPC Pharmaceutical Group Limited from 2013 to 2025. This chart illustrates how CSPC Pharmaceutical Group Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View CSPC Pharmaceutical Group Limited stock price for real-time trading data and today's change.

CSPC Pharmaceutical Group Limited Cash Flow Conversion Ratio Explained

CSPC Pharmaceutical Group Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

CSPC Pharmaceutical Group Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CSPC Pharmaceutical Group Limited ranked by their cash flow conversion efficiency. Also see market cap of CSPC Pharmaceutical Group Limited for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Vedanta Limited NSE:VEDL	0.237x
Ryder System Inc NYSE:R	0.236x
Grace Fabric Technology Co Ltd SHG:603256	0.028x
ENKA Insaat ve Sanayi AS IS:ENKAI	0.022x
Onto Innovation Inc NYSE:ONTO	0.012x
Banque Cantonale Vaudoise SW:BCVN	0.139x
Aegon NV AS:AGN	0.132x
CHINA RE.PO.HO.UNS.ADR/15 F:CRP0	N/A

Annual Cash Flow Conversion Efficiency for CSPC Pharmaceutical Group Limited (2013–2025)

The table below shows the annual cash flow conversion efficiency of CSPC Pharmaceutical Group Limited from 2013 to 2025. Review CVG FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€34.55 Billion ≈ $40.39 Billion	€5.83 Billion ≈ $6.82 Billion	0.169x	+26.06%
2024-12-31	€33.87 Billion ≈ $39.59 Billion	€4.53 Billion ≈ $5.30 Billion	0.134x	+12.21%
2023-12-31	€35.02 Billion ≈ $40.94 Billion	€4.18 Billion ≈ $4.89 Billion	0.119x	-50.49%
2022-12-31	€31.64 Billion ≈ $36.99 Billion	€7.63 Billion ≈ $8.92 Billion	0.241x	+39.47%
2021-12-31	€26.83 Billion ≈ $31.37 Billion	€4.64 Billion ≈ $5.42 Billion	0.173x	-40.76%
2020-12-31	€23.10 Billion ≈ $27.01 Billion	€6.74 Billion ≈ $7.88 Billion	0.292x	+50.49%
2019-12-31	€19.52 Billion ≈ $22.82 Billion	€3.78 Billion ≈ $4.42 Billion	0.194x	-20.83%
2018-12-31	€15.50 Billion ≈ $18.12 Billion	€3.80 Billion ≈ $4.44 Billion	0.245x	-4.12%
2017-12-31	€12.87 Billion ≈ $15.05 Billion	€3.29 Billion ≈ $3.84 Billion	0.255x	-20.08%
2016-12-31	€9.13 Billion ≈ $10.67 Billion	€2.92 Billion ≈ $3.41 Billion	0.320x	+25.21%
2015-12-31	€8.81 Billion ≈ $10.30 Billion	€2.25 Billion ≈ $2.63 Billion	0.255x	+15.17%
2014-12-31	€8.15 Billion ≈ $9.53 Billion	€1.81 Billion ≈ $2.11 Billion	0.222x	+106.60%
2013-12-31	€7.60 Billion ≈ $8.88 Billion	€814.86 Million ≈ $952.66 Million	0.107x	--

About CSPC Pharmaceutical Group Limited

F:CVG Germany Drug Manufacturers - General

Market Cap

$11.73 Billion

€10.04 Billion EUR

Market Cap Rank

#2161 Global

#461 in Germany

Share Price

€0.88

Change (1 day)

-2.60%

52-Week Range

€0.73 - €1.13

All Time High

€1.25